-transparent.png){kind=logo}
Lipopolysaccharide (LPS) and interleukin (IL)-1beta have been reported to induce airway hyperresponsiveness in several animal models. This study investigated the effect of LPS or IL-1beta on bradykinin-induced human isolated bronchi contraction. LPS (100 ng x mL(-1) for 3-6 h) and IL-1beta (3x10(-10) and 3x10(-9) M for 20 min to 3 h) time-dependently potentiated bradykinin-induced contraction. This contraction was abolished, as in control experiments, by indomethacin (10(-6) M) or by the thromboxane (Tx) receptor antagonist GR 32191 but not by the cyclo-oxygenase-2 inhibitor, CGP28238. In contrast, the Tx mimetic U46619-induced contraction of human bronchi was not enhanced IL-1beta pretreatment. In the presence of GR 32191 (10(-6) M), bradykinin induced a prostanoid dependent relaxation that was not significantly modified by IL-1beta pretreatment. Determination of prostanoids in the organ bath fluid showed that bradykinin induced TxB2, the stable metabolite of TxA2, and 6-keto prostaglandin F1alpha, the stable metabolite of PGI2, release. Only TxA2 release was potentiated by IL-1beta. Taken together our results suggest that interleukin-1beta (1-3 h)-induced potentiation of the effect of bradykinin is linked to an increased activity of thromboxane synthase and, in turn, to increased thromboxane synthesis.
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
May 2000,
American journal of respiratory and critical care medicine,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
February 2004,
Naunyn-Schmiedeberg's archives of pharmacology,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
January 1990,
Pulmonary pharmacology,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
October 1994,
American journal of respiratory and critical care medicine,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
January 2012,
International journal of immunopathology and pharmacology,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
January 1988,
The Journal of allergy and clinical immunology,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
June 2020,
Ecotoxicology and environmental safety,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
November 2003,
The Journal of allergy and clinical immunology,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
November 1986,
Fundamental and applied toxicology : official journal of the Society of Toxicology,
M Molimard, and
E Naline, and
E Boichot, and
P Devillier, and
V Lagente, and
B Bégaud, and
C Advenier
February 2007,
Allergy,
